141 related articles for article (PubMed ID: 37624774)
1. Evaluating operational parameters of the careHPV, GeneXpert, AmpFire, and MA-6000 HPV systems for cervical precancer screening: Experience from Battor, Ghana.
Effah K; Wormenor CM; Tekpor E; Amuah JE; Essel NOM; Gedzah I; Kemawor S; Hansen BT; Atuguba BH; Klutsey GB; Sesenu E; Danyo S; Akakpo PK
PLOS Glob Public Health; 2023; 3(8):e0001639. PubMed ID: 37624774
[TBL] [Abstract][Full Text] [Related]
2. Concurrent HPV DNA testing and a visual inspection method for cervical precancer screening: A practical approach from Battor, Ghana.
Effah K; Tekpor E; Wormenor CM; Amuah JE; Essel NO; Atuguba BH; Klutsey GB; Sesenu E; Tay G; Tibu F; Kemawor S; Gedzah I; Morkli EAC; Danyo S; Akakpo PK
PLOS Glob Public Health; 2023; 3(4):e0001830. PubMed ID: 37079498
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the AmpFire and MA-6000 polymerase chain reaction platforms for high-risk human papillomavirus testing in cervical precancer screening.
Effah K; Agbemafle I; Essel NO; Amuah JE; Kotey EN; Antwi-Boasiako E; Kemawor S; Gedzah I; Tekpor E; Wormenor CM; Atuguba BH; Danyo S; Akakpo PK
J Virol Methods; 2023 Jun; 316():114709. PubMed ID: 36924998
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the AmpFire® Multiplex HPV Assay to the Xpert® HPV Assay for detection of human papillomavirus and cervical disease in women with human immunodeficiency virus: a pragmatic performance evaluation.
Moyo S; Ramogola-Masire D; Moraka NO; Tawe L; Noubary F; Motsumi K; Manowe G; Zuze B; Radibe B; Hungwe FTT; Mohammed T; Maphorisa C; Shapiro R; Gaseitsiwe S; Luckett R
Infect Agent Cancer; 2023 May; 18(1):29. PubMed ID: 37165397
[TBL] [Abstract][Full Text] [Related]
5. Self-sampling and HPV DNA testing for cervical precancer screening in a cohort of nuns in Ghana: a cross-sectional cohort study.
Effah K; Tekpor E; Amuah JE; Essel NOM; Kemawor S; Catherine Morkli EA; Lamptey-Mills E; Wormenor CM; Manu LS; Klutsey GB; Danyo S; Akakpo PK
EClinicalMedicine; 2023 Sep; 63():102183. PubMed ID: 37692077
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the AmpFire Multiplex HPV Assay to the Xpert HPV Assay for detection of human papillomavirus and cervical disease in women with human immunodeficiency virus: A pragmatic performance evaluation.
Moyo S; Ramogola-Masire D; Moraka N; Tawe L; Noubary F; Motsumi K; Manowe G; Zuze B; Radibe B; Hungwe FT; Mohammed T; Maphorisa C; Shapiro R; Gaseitsiwe S; Luckett R
Res Sq; 2023 Mar; ():. PubMed ID: 36909533
[No Abstract] [Full Text] [Related]
7. Determining the prevalence of high-risk human papillomavirus infection using a novel cervical precancer screening approach in incarcerated women at the Nsawam Medium Security Prison, Ghana.
Acheampong LK; Effah K; Amuah JE; Tekpor E; Wormenor CM; Gedzah I; Kemawor S; Kachana AC; Danso PA; Essel NOM; Asomaning M; Agyiri D; Akakpo PK
Ecancermedicalscience; 2021; 15():1248. PubMed ID: 34267804
[TBL] [Abstract][Full Text] [Related]
8. Options in human papillomavirus (HPV) detection for cervical cancer screening: comparison between full genotyping and a rapid qualitative HPV-DNA assay in Ghana.
Obiri-Yeboah D; Adu-Sarkodie Y; Djigma F; Akakpo K; Aniakwa-Bonsu E; Amoako-Sakyi D; Jacques S; Mayaud P
Gynecol Oncol Res Pract; 2017; 4():5. PubMed ID: 28270915
[TBL] [Abstract][Full Text] [Related]
9. Agreement between careHPV and hybrid capture 2 in detecting high-risk HPV in women in Tanzania.
Katanga J; Kjaer SK; Manongi R; Pembe AB; Iftner T; Waldstrom M; Mwaiselage J; Rasch V
Acta Obstet Gynecol Scand; 2021 Apr; 100(4):786-793. PubMed ID: 33497480
[TBL] [Abstract][Full Text] [Related]
10. Screening for cervical cancer among HIV-positive and HIV-negative women in Cameroon using simultaneous co-testing with careHPV DNA testing and visual inspection enhanced by digital cervicography: Findings of initial screening and one-year follow-up.
Cholli P; Bradford L; Manga S; Nulah K; Kiyang E; Manjuh F; DeGregorio G; Ogembo RK; Orock E; Liu Y; Wamai RG; Sheldon LK; Gona PN; Sando Z; Welty T; Welty E; Ogembo JG
Gynecol Oncol; 2018 Jan; 148(1):118-125. PubMed ID: 29153541
[TBL] [Abstract][Full Text] [Related]
11. Detection and genotyping of HPV-DNA through different types of diagnostic platforms in liquid-based cervical-cytology samples.
Cassani B; Soldano G; Finocchiaro D; Conti S; Bulfamante A; Lemorini G; Bulfamante G
Pathologica; 2018 Dec; 110(4):294-301. PubMed ID: 30799441
[TBL] [Abstract][Full Text] [Related]
12. Performance of careHPV for detecting high-grade cervical intraepithelial neoplasia among women living with HIV-1 in Burkina Faso and South Africa: HARP study.
Segondy M; Kelly H; Magooa MP; Djigma F; Ngou J; Gilham C; Omar T; Goumbri-Lompo O; Michelow P; Doutre S; Clavero O; Chikandiwa A; Sawadogo B; Didelot MN; Costes V; Méda N; Delany-Moretlwe S; Mayaud P
Br J Cancer; 2016 Aug; 115(4):425-30. PubMed ID: 27434037
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of careHPV, Cervista Human Papillomavirus, and Hybrid Capture 2 Methods in Diagnosing Cervical Intraepithelial Neoplasia Grade 2+ in Xinjiang Uyghur Women.
Tuerxun G; Yukesaier A; Lu L; Aierken K; Mijiti P; Jiang Y; Abulizi A; Zhang Y; Abuduxikuer G; Abulizi G; Li H
Oncologist; 2016 Jul; 21(7):825-31. PubMed ID: 27317575
[TBL] [Abstract][Full Text] [Related]
14. Cervical precancer screening with HPV DNA testing and mobile colposcopy in women with sickle cell disease in Accra, Ghana.
Dei-Adomakoh Y; Effah K; Tekpor E; Crabbe S; Amuah JE; Wormenor CM; Tay G; Asare EV; Kemawor S; Danyo S; Morkli EAC; Tibu F; Essel NO; Akakpo PK
Ecancermedicalscience; 2023; 17():1571. PubMed ID: 37533951
[TBL] [Abstract][Full Text] [Related]
15. Cross comparison of AmpFire HPV genotyping assay and Roche human papillomavirus (HPV) linear array for HPV genotyping of anal swab samples.
Connors KA; Abbott S; Jair K; Daniels J; Lintner M; Klein D; Wimpleberg A; Jordan JA
J Virol Methods; 2021 Jun; 292():114113. PubMed ID: 33652016
[TBL] [Abstract][Full Text] [Related]
16. Self-collected vaginal sampling for the detection of genital human papillomavirus (HPV) using careHPV among Ghanaian women.
Obiri-Yeboah D; Adu-Sarkodie Y; Djigma F; Hayfron-Benjamin A; Abdul L; Simpore J; Mayaud P
BMC Womens Health; 2017 Sep; 17(1):86. PubMed ID: 28950841
[TBL] [Abstract][Full Text] [Related]
17. Integrating human papillomavirus testing as a point-of care service using GeneXpert platforms: Findings and lessons from a Kenyan pilot study (2019-2020).
Mwenda V; Bor JP; Nyangasi M; Njeru J; Olwande S; Njiri P; Arbyn M; Weyers S; Tummers P; Temmerman M
PLoS One; 2023; 18(5):e0286202. PubMed ID: 37228154
[TBL] [Abstract][Full Text] [Related]
18. High-risk human papillomavirus genotype distribution among women living with HIV; implication for cervical cancer prevention in a resource limited setting.
Akakpo PK; Ken-Amoah S; Enyan NIE; Agyare E; Salia E; Baidoo I; Derkyi-Kwarteng L; Asare M; Adjei G; Addo SA; Obiri-Yeboah D
Infect Agent Cancer; 2023 May; 18(1):33. PubMed ID: 37237313
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic accuracy of cervical cancer screening and screening-triage strategies among women living with HIV-1 in Burkina Faso and South Africa: A cohort study.
Kelly HA; Chikandiwa A; Sawadogo B; Gilham C; Michelow P; Lompo OG; Omar T; Zan S; Magooa P; Segondy M; Nagot N; Meda N; Delany-Moretlwe S; Mayaud P;
PLoS Med; 2021 Mar; 18(3):e1003528. PubMed ID: 33661957
[TBL] [Abstract][Full Text] [Related]
20. Accuracy of triage strategies for human papillomavirus DNA-positive women in low-resource settings: A cross-sectional study in China.
Wang M; Hu S; Zhao S; Zhang W; Pan Q; Zhang X; Chen F; Han J; Ma J; Smith JS; Qiao Y; Zhou C; Zhao F
Chin J Cancer Res; 2017 Dec; 29(6):496-509. PubMed ID: 29353972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
